Evidence map›Paper›PMID 39459858›Full record

ReviewViruses2024

Ubiquitin-Mediated Effects on Oncogenesis during EBV and KSHV Infection.

Rachel Mund, Christopher B Whitehurst

Abstract readReview
In one paragraph

Review in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Rachel MundDepartment of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.ORCID 0009-0004-9027-9822
Christopher B WhitehurstDepartment of Pathology, Microbiology and Immunology, New York Medical College, Valhalla, NY 10595, USA.ORCID 0000-0003-4740-2317

Funding

Targeting EBV's Deubiquitinating Activity for TherapyR21AI180281 · NIAID · NEW YORK MEDICAL COLLEGE · PI WHITEHURST, CHRISTOPHER BENTON · 2024 to 2025
$454k
New York Medical College Start-up fundsNIAID NIH HHS R21 AI180281NIH NIAID 1R21AI180281-01A1
6 · The paper itself

Abstract

The

Indexed as

CarcinogenesisEpstein-Barr Virus InfectionsHerpesvirus 4, HumanHerpesvirus 8, HumanUbiquitinVirus LatencyAnimalsHerpesviridae InfectionsHost-Pathogen InteractionsHumansSarcoma, KaposiViral ProteinsVirus ReplicationUbiquitinViral ProteinsEBVEpstein–Barr VirusgammaherpesvirusKaposi Sarcoma-associated HerpesvirusKSHVoncogenesispost-translational modificationproteasomal degradationtumor virusubiquitin

Identifiers

PMID39459858
PMCPMC11512223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.